|
Sanchis J, Soler M, Nunez J, Ruiz V, Bonanad C, Formiga F, Valero E, Martinez-Selles M, Marin F, Ruescas A, Garcia-Blas S, Minana G, Abu-Assi E, Bueno H, Ariza-Sole A. Comorbidity assessment for mortality risk stratification in elderly patients with acute coronary syndrome. Eur J Intern Med. 2019 Apr;62:48-53. doi: 10.1016/j.ejim.2019.01.018. Epub 2019 Jan 31. PubMed PMID: 30711360.
AÑO: 2019; IF: 4.329
|
30711360
|
Orenes-Pinero E, Esteve-Pastor MA, Ruiz-Nodar JM, Quintana-Giner M, Veliz-Martinez A, Tello-Montoliu A, Macias-Villanego MJ, Pernias-Escrig V, Vicente-Ibarra N, Carrillo-Aleman L, Sandin-Rollan M, Martinez J, Lozano T, Rivera-Caravaca JM, Marin F. Under-prescription of novel antiplatelet drugs in patients with acute coronary syndrome and previous cardiovascular disease. Minerva Med. 2019 Oct;110(5):410-418. doi: 10.23736/S0026-4806.19.05859-2. Epub 2019 May 6. PubMed PMID: 31081301.
AÑO: 2019; IF: 3.031
|
|
Lorente V, Ariza-Sole A, Jacob J, Formiga F, Marin F, Martinez-Selles M, Viana-Tejedor A, Bardaji A, Sionis A, Palau-Vendrell A, Diez-Villanueva P, Aboal J, Gonzalez-Salvado V, Bueno H. Criteria for admitting elderly patients with acute coronary syndrome to critical care units from Spanish hospital emergency departments: a LONGEVO-SCA cohort study. Emergencias. 2019 Jun;31(3):154-160. English, Spanish. PubMed PMID: 31210446.
AÑO: 2019; IF: 3.173
|
|
SEC Working Group for the 2018 ESC ESH Guidelines on Arterial Hypertension; Expert Reviewers for the 2018 ESC ESH Guidelines on Arterial Hypertension; SEC Guidelines Committee. Comments on the 2018 ESC/ESH Guidelines for the Management of Arterial Hypertension. Rev Esp Cardiol (Engl Ed). 2019 Feb;72(2):104-108. doi: 10.1016/j.rec.2018.12.001. No abstract available. English, Spanish. PubMed PMID: 30704721.
AÑO: 2019; IF: 4.642
|
|
Tello-Montoliu A, Ruiz-Nodar JM, Esteve-Pastor MA, Veliz-Martinez A, Orenes-Pinero E, Macias-Villanego MJ, Lozano T, Carrillo-Aleman L, Vicente-Ibarra N, Pernias-Escrig V, Martinez-Martinez JG, Rivera-Caravaca JM, Marin F. Chronic Kidney Disease and Third-Generation P2Y12 Inhibitors Use in Patients With Acute Coronary Syndrome: Impact on the Prognosis at 1 Year. J Clin Pharmacol. 2019 Feb;59(2):295-302. doi: 10.1002/jcph.1318. Epub 2018 Sep 12. PubMed PMID: 30207603.
AÑO: 2019; IF: 2.425
|